Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?

Affiliations

Editorial

Martin S Maron. Circ Cardiovasc Imaging. 2017 Jul.

. 2017 Jul;10(7):e006674.

doi: 10.1161/CIRCIMAGING.117.006674.

¹ From the Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA. mmaron@tuftsmedicalcenter.org.

No abstract available

Keywords: Editorials; biomarkers; cardiomyopathy, hypertrophic; death, sudden; gadolinium; risk.

Comment on

Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy.
Hiemstra YL, Debonnaire P, Bootsma M, van Zwet EW, Delgado V, Schalij MJ, Atsma DE, Bax JJ, Marsan NA. Hiemstra YL, et al. Circ Cardiovasc Imaging. 2017 Jul;10(7):e005706. doi: 10.1161/CIRCIMAGING.116.005706. Circ Cardiovasc Imaging. 2017. PMID: 28679523